Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 2—February 2008
Research

Severe Streptococcus pyogenes Infections, United Kingdom, 2003–2004

Theresa L. Lamagni*Comments to Author , Shona Neal*, Catherine Keshishian*, Neelam Alhaddad*, Robert C. George*, Georgia Duckworth*, Jaana Vuopio-Varkila†, and Androulla Efstratiou*
Author affiliations: *Health Protection Agency, London, United Kingdom; †National Public Health Institute, Helsinki, Finland;

Main Article

Table 2

Clinical markers of severe Streptococcus pyogenes infection in the United Kingdom, 2003–2004*

Marker All case-patients (n = 2,611), no. (%) Bacteremia with no defined focus (n = 558), no. (%) Pneumonia (n = 309), no. (%) Cellulitis (n = 881), no. (%) Septic arthritis (n = 220), no. (%) Necrotizing fasciitis (n = 136), no. (%) Puerperal sepsis (n = 58), no. (%)
Clinical severity (n = 2,611)
Hypotensive shock 494 (19) 101 (18) 70 (23) 155 (18) 43 (20) 80 (59) 13 (22)
STSS (hypotension +
>2 listed below) 196 (8) 28 (5) 27 (9) 63 (7) 18 (8) 55 (40) 3 (5)
Renal impairment 381 (15) 69 (12) 50 (16) 149 (17) 40 (18) 58 (43) 3 (5)
Respiratory distress 288 (11) 41 (7) 113 (37) 67 (8) 20 (9) 33 (24) 1 (2)
Erythematous rash 231 (9) 30 (5) 15 (5) 135 (15) 13 (6) 17 (13) 4 (7)
Soft-tissue necrosis 254 (10) 0 8 (3) 116 (13) 13 (6) 136 (100) 3 (5)
Liver abnormality 185 (7) 31 (6) 23 (7) 65 (7) 14 (6) 31 (23) 3 (5)
Disseminated
intravascular
coagulation 131 (5) 21 (4) 14 (5) 40 (5) 10 (5) 35 (26) 6 (10)
Admission to ICU
(n = 2,292) 451 (20) 76 (16) 68 (24) 136 (17) 40 (21) 101 (77) 8 (16)
Surgical intervention
(n = 1,885) 443 (24) 21 (6) 19 (8) 131 (20) 106 (63) 106 (87) 10 (24)
Death within 7 d
(n = 2,192) 413 (19) 97 (22) 87 (32) 121 (16) 17 (9) 43 (34) 2 (4)

*STSS, streptococcal toxic shock syndrome; ICU, intensive care unit.

Main Article

Page created: July 08, 2010
Page updated: July 08, 2010
Page reviewed: July 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external